Related Experiment Video
Updated: May 5, 2026

08:57
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
3.1K
Dissecting NMOSD pathogenesis through animal models: a mechanism-oriented systems perspective
Siqi Qiu1, Yingyu Zhang1, Xiaoshuang Wang1
1Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China.
Frontiers in Immunology
|May 4, 2026
Summary
Neuromyelitis optica spectrum disorder (NMOSD) research uses animal models to study autoimmune attacks on astrocytes targeting aquaporin-4 (AQP4). These models offer insights into disease mechanisms but have limitations in fully replicating human NMOSD.
Area of Science:
- Neuroimmunology
- Autoimmune Diseases
- Demyelinating Disorders
Background:
- Neuromyelitis optica spectrum disorder (NMOSD) is a CNS demyelinating disease driven by autoimmune inflammation.
- Antibody-mediated injury of astrocytes, targeting aquaporin-4 (AQP4), is a key pathogenic mechanism in NMOSD.
- Developing accurate animal models for NMOSD is challenging due to immune tolerance limitations.
Purpose of the Study:
- To review and analyze experimental systems modeling NMOSD pathogenesis.
- To evaluate how well current models recapitulate key pathological features of NMOSD.
- To identify limitations of existing models and propose priorities for next-generation models.
Main Methods:
- Survey of experimental systems across four mechanistic themes: immune tolerance breakdown, T-B cell collaboration, antibody-mediated injury, and pro-inflammatory milieus.
- Evaluation of model design rationale, pathological feature representation, and interpretational limitations.
- Discussion of how animal study findings inform therapeutic target discovery.
Main Results:
- Existing NMOSD models capture complementary, partially overlapping aspects of pathogenesis.
- These platforms provide a mechanism-oriented framework for understanding disease drivers.
- Significant discrepancies remain between experimental systems and the heterogeneous, dynamic course of human NMOSD.
Conclusions:
- Animal models are crucial for NMOSD research but do not fully replicate human disease complexity.
- Understanding model limitations is key to advancing therapeutic development for NMOSD.
- Future research should focus on developing next-generation models with enhanced translational relevance for NMOSD.

